by Jordana Choucair | Jul 29, 2022 | Life Sciences
he Biden administration is planning a September campaign for reformulated COVID-19 booster shots. The vaccines, which Pfizer Inc. and Moderna Inc. said they could deliver on that timeline, would be available for all adults and potentially children. The companies...
by Jordana Choucair | Jul 28, 2022 | Life Sciences
The federal government is set to announce today the release of almost 800,000 doses of monkeypox vaccine. Health and Human Services Secretary Xavier Becerra said that the doses will be released as soon as the Food and Drug Administration (FDA) clears them. The FDA...
by Jordana Choucair | Jul 26, 2022 | Life Sciences
A federal appeals court in New York upheld a lower-court ruling against Pfizer Inc. that said the drugmaker’s Direct Copay Assistance Program violated an anti-kickback law. The federal government had argued that Pfizer’s financial support for reimbursable...
by Jordana Choucair | Jul 25, 2022 | Life Sciences
The White House will convene top federal officials, scientists, and Pfizer and Moderna pharmaceutical executives tomorrow to discuss new COVID-19 vaccine technologies. Ashish Jha, the White House’s COVID-19 response coordinator, acknowledged that more money from...
by Jordana Choucair | Jul 21, 2022 | Life Sciences
Senate Finance Chairman Ron Wyden outlined several additional prescription drug reforms that he wants Democrats to tackle after the reconciliation bill. Wyden said that plans to allow Medicare to negotiate drug prices and to fine drugmakers that hike prices at a...
by Jordana Choucair | Jul 20, 2022 | Life Sciences
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices voted unanimously to endorse the Novavax COVID-19 vaccine. CDC Director Rochelle Walensky subsequently authorized its use as a primary series for adults 18. The vaccine...
Recent Comments